Table 2.
Confidence domains | Median (IQR) confidence scores | p value1 | |
---|---|---|---|
Provided advice <10 times in last 12 months n = 17 |
Provided advice >10 times in last 12 months n = 18 |
||
Therapeutic target range | 2 (1–3) | 1 (1–2) | 0.02 |
Timing of first blood concentration | 2 (1–4) | 2 (1–3) | 0.11 |
General advice to prescribers | 2 (2–4) | 2 (1–3) | 0.009 |
Loading dose | 2 (1–4) | 2 (1–3) | 0.10 |
Amending dosing based on TDM | 3 (2–3) | 2 (1–3) | <0.001 |
Frequency of TDM | 2 (1–3) | 2 (1–4) | 0.85 |
Administration rate | 2 (1–4) | 2 (1–5) | 0.75 |
Management of infusion related reactions | 3 (1–5) | 2.5 (1–5) | 0.63 |
1 = strongly agree, 2 = agree, 3 = neutral, 4 = disagree, 5 = strongly disagree
TDM therapeutic drug monitoring, IQR interquartile range, 1Using Mann-Whitney